Controlled Drug Bioavailability, vol. 1: Drug Product Design and Performance

1985 ◽  
Vol 74 (7) ◽  
pp. 801
Author(s):  
John H. Wood
2019 ◽  
Vol 15 (3) ◽  
pp. 318-324 ◽  
Author(s):  
Nélio Drumond

Abstract Purpose Additional costs for healthcare provision are expected for cases where the level of care provided is not according to the patient’s needs and demands. To address these issues and reduce costs, fundamental changes need to be made on how healthcare provision is administered to patients, which raises the opportunity for the implementation of patient-centric systems. Methods This review addresses the importance of implementing a patient-centric approach in current healthcare provision and emphasizes the need to adjust current development and business models for a successful application of patient-centric care. Results To increase awareness and avoid confusion, the purpose of patient-centric pharmaceutical drug product design is reviewed in detail and future market opportunities for patient-centric drug products are discussed. Conclusions With regard to solid oral dosage forms, the subject of patient-centric pharmaceutical drug product design will focus more on the customization of existing technologies (e.g., dosage form size reduction) to address the needs of specific patient populations such as pediatrics, geriatrics, dysphagia patients, or the cognitively impaired.


2017 ◽  
Vol 268 ◽  
pp. 40-48 ◽  
Author(s):  
Natalja Genina ◽  
Johan Peter Boetker ◽  
Stefano Colombo ◽  
Necati Harmankaya ◽  
Jukka Rantanen ◽  
...  

2021 ◽  
pp. 113990
Author(s):  
Héloïse Ragelle ◽  
Sima Rahimian ◽  
Elia A. Guzzi ◽  
Peter D. Westenskow ◽  
Mark W. Tibbitt ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document